GlassScriptPhysician profile
Lee A Erbe
NPI 1588673917
$3,315.58
in general payments reported to CMS, 2019-2025
24 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $992 · 2022: $1,884 · 2023: $240 · 2024: $67.77 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $440.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $440.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,183.32 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Insulet Corporation | $375.86 | 2021-2025 | Omnipod |
| Lilly USA, LLC | $307.70 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $226.71 | 2021-2023 | Gvoke Hypopen |
| Abbott Laboratories | $209.92 | 2021-2023 | Freestyle Libre 3 |
| Horizon Therapeutics Plc | $171.24 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $154.21 | 2021-2022 | |
| Rhythm Pharmaceuticals, INC. | $133.07 | 2022 | |
| Sanofi-Aventis U.S. LLC | $127.42 | 2021-2023 | |
| Abbvie INC. | $69.32 | 2021-2022 | |
| Medtronic, INC. | $53.66 | 2022-2025 | Minimed 780g |
| Astrazeneca Pharmaceuticals LP | $49.29 | 2021-2022 | |
| Zealand Pharma US, INC. | $38.99 | 2021-2022 | |
| Corcept Therapeutics | $34.91 | 2024 | Korlym |
| Amarin Pharma, INC. | $28.98 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cequr Corporation | $22.29 | 2022 | |
| Arbor Pharmaceuticals, INC. | $22.04 | 2022 | |
| Radius Health, INC. | $21.10 | 2025 | |
| Renalytix Ai, INC. | $18.71 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $14.81 | 2021 | |
| Novartis Pharmaceuticals Corporation | $13.55 | 2023 | |
| Dexcom, INC. | $13.30 | 2022 | |
| Lifescan, INC. | $12.79 | 2022 | |
| Vifor Pharma, INC. | $12.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Erbe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.